Pay in 4 interest-free payments of $6.78 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
Semaglutide (Novo Nordisk A/S, Denmark) is a subcutaneously administered GLP-1 analogue for the treatment of T2D
Incretins, such as GLP-1 and glucose-dependent insulinotropic polypeptide (GIP), are secreted by entero-endocrine cells of the gastrointestinal tract to stimulate glucose-dependent insulin secretion and beta-cell proliferation
Do not rely on verbal promises from customer service
Its also found in Wegovy, approved for weight loss
Wait at least 30 minutes before eating breakfast, drinking tea or coffee, or taking any other oral medications
:max_bytes(150000):strip_icc()/Health-GettyImages-2187000770-0677e00e83464cab947191790a5ef595.jpg)
US$ 22.19
US$ 29.00
US$ 23.49
